Future Horizons in the UK Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Market Segment
Upcoming SlideShare
Loading in...5
×
 

Future Horizons in the UK Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Market Segment

on

  • 193 views

 

Statistics

Views

Total Views
193
Views on SlideShare
193
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Future Horizons in the UK Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Market Segment Future Horizons in the UK Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Market Segment Document Transcript

  • Future Horizons in the UK Infectious Disease Testing Market:Supplier Shares and Sales Forecasts for 100 Tests by MarketSegmentReport Details:Published:August 2012No. of Pages: 978Price: Single User License – US$5900Highlights•Comprehensive 978-page analysis of the UK microbiology testing market.•Major issues pertaining to the UK microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.•Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.•Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in UK hospitals, blood banks, public health and commercial laboratories.•Instrumentation technologies and feature comparison of leading analyzers.•Sales and market shares of leading suppliers.•Emerging diagnostic technologies and their potential market applications.•Product development opportunities.•Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.•Business opportunities and strategic recommendations for suppliers.Contains: 978 pages and 159 tables.Get your copy of this report @http://www.reportsnreports.com/reports/187747-future-horizons-in-the-uk-infectious-disease-testing-market-supplier-shares-and-sales-forecasts-for-100-tests-by-market-segment.htmlMajor points covered in Table of Contents of this report includeIntroductionWorldwide Market and Technology Overview
  • A. Major Infectious Disease Tests1. AIDSa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs2. Adenovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugsd. Adeno-Associated Viruses(AAV)3. Aeromonasa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs4. Anthrax/Bacillus Anthracisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs5. Arbovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs6. Babesiosisa. Background7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs8. Blastocystis Hominisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs9. Brucellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs10. Campylobactera. Backgroundb. Diagnostic Testsc. Vaccines and Drugs11. Candida
  • a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs12. Chagas Diseasea. Background13. Chancroida. Backgroundb. Diagnostic Testsc. Vaccines and Drugs14. Chlamydiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs15. Clostridium Difficilea. Backgroundb. Diagnostic Testsc. Drugs and Vaccines16. Coronavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs17. Coxsackievirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs18. Creutzfeldt-Jakob’s Diseasea. Backgroundb. Diagnostic Testsc. Vaccines19. Cryptosporidium Parvuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs20. Cyclospora Cayetanensisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs21. Cytomegalovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs22. Ebola Virus
  • a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs23. E. Colia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs24. EchoVirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs25. Encephalitisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs26. Enterovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs27. Epstein-Barr Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs28. Giardia Lambliaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs29. Gonorrheaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs30. Granuloma Inguinalea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs31. Hantavirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs32. Helicobacter Pyloria. Backgroundb. Diagnostic Tests
  • c. Vaccines and Drugs33. Hepatitisa. Backgroundb. Hepatitis Ac. Hepatitis Bd. Hepatitis Ce. Vaccines and Drugs34. Herpes Simplex Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs35. Human Herpes Virus-6 (HHV-6)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs36. Influenza Virusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs37. Legionellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs38. Lyme Diseasea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs39. Lymphogranuloma Venereum (LGV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs40. Malariaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs41. Measles (Rubeola)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs42. Meningitisa. Backgroundb. Diagnostic Tests
  • c. Vaccines and Drugs43. Microsporidiuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs44. Mononucleosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs45. Mumpsa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs46. Mycoplasmaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs47. Papillomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs48. Parvovirus B19a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs49. Pneumoniaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs50. Polyomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs51. Pseudomonas Aeruginosaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs52. Rabiesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs53. Respiratory Syncytial Virus (RSV)
  • a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs54. RhinoVirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs55. RotaVirus (REOVIRUS)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs56. Rubella(MEASLES)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs57. Salmonellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs58. Septicemiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs59. Shigellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs60. Staphylococcus Aureusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs61. Streptococcia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs62. Syphilisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs63. Toxoplasmosisa. Backgroundb. Diagnostic Tests
  • c. Vaccines and Drugs64. Trichomonas Vaginalisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs65. Tuberculosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs66. Vibrioa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs67. West Nile Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs68. Yersinaa. Backgroundb. Diagnostic Testsc. Vaccines and DrugsB. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher,BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other SuppliersC. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Scattering5. Information Technology6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. Diagnostic Imaging11. Gel Microdroplets12. OtherU.K.A. Executive SummaryB. Business Environment
  • C. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. InstrumentationB. Reagent Kits and Test Systems/PanelsC. Computers, Software and AutomationD. Auxiliary ProductsDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation Potential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive Assessments- Abbott- Affymetrix- Beckman Coulter/Danaher- Becton Dickinson- bioMerieux- Bio-Rad- Cepheid- Diamedix- DiaSorin- Eiken Chemical- Enzo Biochem- Fujirebio- Gen-Probe- Hologic
  • - ID Biomedical- Innogenetics/Solvay- Kreatech- Life Technology- Lonza- Nanogen/Elitech- Novartis Diagnostics- Ortho-Clinical Diagnostics- Qiagen- Roche- Scienion- Sequenom- SeraCare- Siemens- Takara Bio- Thermo Fisher- Wallac- WakoList of TablesMajor Companies Developing or Marketing AIDS TestsMajor Companies Developing or Marketing Adenovirus TestsMajor Companies Developing or Marketing Bartonella TestsMajor Companies Developing or Marketing Campylobacter TestsMajor Companies Developing or Marketing Candida TestsMajor Companies Developing or Marketing Chlamydia TestsMajor Companies Developing or Marketing Clostridium TestsMajor Companies Developing or Marketing Coronavirus TestsMajor Companies Developing or Marketing Cryptosporidium TestsMajor Companies Developing or Marketing CMV TestsMajor Companies Developing or Marketing Echovirus TestsMajor Companies Developing or Marketing Enterovirus TestsMajor Companies Developing or Marketing EBV TestsMajor Companies Developing or Marketing Giardia TestsMajor Companies Developing or Marketing Gonorrhea TestsMajor Companies Developing or Marketing Hantavirus TestsMajor Companies Developing or Marketing Helicobacter Pylori TestsMajor Companies Developing or Marketing Hepatitis TestsMajor Companies Developing or Marketing Herpes TestsMajor Companies Developing or Marketing Influenza TestsMajor Companies Developing or Marketing Legionella TestsMajor Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma TestsMajor Companies Developing or Marketing Malaria TestsMajor Companies Developing or Marketing Measles TestsMajor Companies Developing or Marketing Meningitis TestsMajor Companies Developing or Marketing Microsporidium TestsMajor Companies Developing or Marketing Mononucleosis TestsMajor Companies Developing or Marketing Mumps TestsMajor Companies Developing or Marketing Mycoplasma TestsMajor Companies Developing or Marketing Papilloma Virus TestsMajor Companies Developing or Marketing Parvovirus TestsMajor Companies Developing or Marketing Pneumonia TestsMajor Companies Developing or Marketing RSV TestsMajor Companies Developing or Marketing Rotavirus TestsMajor Companies Developing or Marketing Rubella TestsMajor Companies Developing or Marketing Salmonella TestsMajor Companies Developing or Marketing Septicemia TestsMajor Companies Developing or Marketing Shigella TestsMajor Companies Developing or Marketing Staphylococci TestsMajor Companies Developing or Marketing Streptococci TestsMajor Companies Developing or Marketing Syphilis TestsMajor Companies Developing or Marketing Toxoplasmosis TestsMajor Companies Developing or Marketing Trichomonas TestsMajor Companies Developing or Marketing Tuberculosis TestsMajor Companies Developing or Marketing West Nile TestsMajor Companies Developing or Marketing Yersinia TestsU.K. Summary TableAll Infectious Diseases Test Volume and DiagnosticsSales Forecast by Market SegmentU.K.Laboratories Performing Infectious Disease Testsby Market SegmentU.K.Hospital Laboratories Performing Infectious DiseaseTests by Bed SizeU.K.Commercial/Private Laboratories Performing InfectiousDisease Tests by Annual Test VolumeU.K.All Market Segments Infectious Disease Test Volume ForecastU.K.Hospital Laboratories Infectious Disease Test Volume Forecast
  • U.K.Blood Banks Infectious Disease Test Volume ForecastU.K.Public Health Laboratories Infectious Disease TestVolume ForecastU.K.Commercial/Private Laboratories Infectious DiseaseTest Volume ForecastU.K.All Market Segments Infectious Disease DiagnosticsMarket ForecastU.K.Hospital Laboratories Infectious Disease DiagnosticsMarket ForecastU.K.Blood Banks Infectious Disease Diagnostics Market ForecastU.K.Public Health Laboratories Infectious DiseaseDiagnostics Market ForecastU.K.Commercial/Private Laboratories Infectious DiseaseDiagnostics Market ForecastU.K.HIV or HIV I/HIV II Test Volume and Diagnostics SalesForecast by Market SegmentU.K.HIVAg Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Western Blot/Other Confirmatory Test Volume andDiagnostics Sales Forecast by Market SegmentU.K.Adenovirus Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.AeromonadsTest Volume and Diagnostics Sales Forecast by Market SegmentU.K. BEA Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.
  • Blastocystis Hominis Test Volume and Diagnostics SalesForecast by Market SegmentU.K.CampylobacterTest Volume and Diagnostics Sales Forecastby Market SegmentU.K.CandidaTest Volume and Diagnostics Sales Forecastby Market SegmentU.K.ChancroidTest Volume and Diagnostics Sales Forecastby Market SegmentU.K.Chlamydia Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Clostridium Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Coronavirus Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.CoxsackieVirus Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Cryptosporidium Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Cyclospora Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.CMV Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.E. Coli Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Echovirus Test Volume and Diagnostics Sales Forecastby Market Segment
  • U.K.Encephalitis Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Enterovirus Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.EBV Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Giardia Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Gonorrhea Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Granuloma Inguinale Test Volume and Diagnostics SalesForecast by Market SegmentU.K.Helicobacter Pylori Test Volume and Diagnostics SalesForecast by Market SegmentU.K.HAV NAT Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.HBV NAT Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.HbsAg Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Hepatitis C Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Anti-HBc Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Anti-HBs Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.
  • Anti-HAV Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Hepatitis Delta Test Volume and Diagnostics SalesForecast by Market SegmentU.K.HBcAg Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.HBeAg Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Herpes Simplex I and II Test Volume and DiagnosticsSales Forecast by Market SegmentU.K.Herpes Type VI Test Volume and DiagnosticsSales Forecast by Market SegmentU.K.HTLV I or HTLV I/HTLV II Test Volume and DiagnosticsSales Forecast by Market SegmentU.K.Influenza Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Legionella Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Lyme Disease Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Lymphogranuloma Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Malaria Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Measles Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Meningitis Test Volume and Diagnostics Sales Forecastby Market Segment
  • U.K.Microsporidium Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Mononucleosis Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Mumps Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Mycoplasma Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Papilloma Virus Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Parvovirus Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Pneumonia Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Polyomaviruses Test Volume and Diagnostics SalesForecast by Market SegmentU.K.Pseudomonas Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Rabies Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.RSV Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Rhinovirus Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Rotavirus Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Rubella Test Volume and Diagnostics Sales Forecast
  • by Market SegmentU.K.Salmonella Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Septicemia Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Shigella Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Staphylococci Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Streptococci Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Syphilis Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Toxoplasmosis Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Trichomonas Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Tuberculosis Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Vibrio Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.West Nile Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.Yersinia Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.AIDS Testing Market Diagnostics Salesby Major Supplier
  • U.K.Campylobacter Testing Market Diagnostics Salesby Major SupplierU.K.Candida Testing Market Diagnostics Salesby Major SupplierU.K.Gonorrhea Testing Market Diagnostics Salesby Major SupplierU.K.Hepatitis Testing Market Diagnostics Salesby Major SupplierU.K.Hepatitis C Testing Market Diagnostics Salesby Major SupplierU.K.Influenza Testing Market Diagnostics Salesby Major SupplierU.K.Mycoplasma Testing Market Diagnostics Salesby Major SupplierU.K.Pneumonia Testing Market Diagnostics Salesby Major SupplierU.K.RSV Testing Market Diagnostics Sales by Major SupplierU.K.Rubella Testing Market Diagnostics Salesby Major SupplierU.K.Septicemia Testing Market Diagnostics Salesby Major SupplierU.K.Shigella Testing Market Diagnostics Salesby Major SupplierU.K.Streptococci Testing Market Diagnostics Salesby Major SupplierU.K.Syphilis Testing Market Diagnostics Salesby Major Supplier
  • U.K.Tuberculosis Testing Market Diagnostics Salesby Major SupplierContact: sales@reportsandreports.com for more information.